Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II

To assess clinical outcomes of patients with severe, cicatricial ocular surface disease (OSD) implanted with the currently marketed design of the Boston keratoprosthesis type II (BK2). Retrospective cohort study. Records of consecutive patients undergoing BK2 implantation from June 2009 to March 202...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of ophthalmology 2022-11, Vol.243, p.42-54
Hauptverfasser:	Saini, Chhavi, Chen, Teresa C., Young, Lucy H., Vavvas, Demetrios G., Vangel, Mark, Papaliodis, George N., Mukai, Shizuo, Turalba, Angela V., Rhee, Douglas J., Wu, David M., Eliott, Dean, Miller, John B., Song, Brian J., Shen, Lucy Q., Pasquale, Louis R., Chodosh, James
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics Clinical outcomes Cornea FDA approval General anesthesia Glaucoma Health Insurance Portability & Accountability Act 1996-US Patients Review boards Surgery Surgical outcomes Sutures Titanium
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!